Skip to main content
. 2022 Jul 1;93(3):e2022236. doi: 10.23750/abm.v93i3.13103

Table 2.

Summary of benefits and risks associated with mRNA COVID-19 vaccines booster dose

Benefits Risks *
Infection rate Cardiac related complications such as myocarditis and pericarditis
Severity of Signs and Symptoms Lung related complications such as pneumonitis and interstitial lung disease
Overall Hospitalization Cutaneous adverse reactions such as hypersensitivity and psoriasis, including exacerbation of the symptoms
Intensive Care Unit (ICU) Hospitalization Hematologic related such as thrombocytopenia
Death rate Efficacy against new variants
Waning immunity over time

* Adverse events/reactions are mostly short-term and differ according to certain demographics such as age, ethnicity, etc.